6 курс / Кардиология / Протокол_АКК_и_ААС_Специальное_дополнение_по_применению_бета_адреноброкаторов

573.Terzi A, Furlan G, Chiavacci P, et al. Prevention of atrial tachyarrhythmias after non-cardiac thoracic surgery by infusion of magnesium sulfate. Thorac Cardiovasc Surg. 1996;44:300–3.

574.Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.

575.Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–8.

576.Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.

577.Kowey PR, Marinchak RA, Rials SJ, et al. Intravenous amiodarone. J Am Coll Cardiol. 1997;29:1190–8.

578.Scheinman MM, Levine JH, Cannom DS, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation. 1995;92:3264–72.

579.Kowey PR, Levine JH, Herre JM, et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation. 1995;92:3255–63.

580.Khuri SF, Daley J, Henderson W, et al. Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program. Ann Surg. 1999;230:414–29.

581.Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med. 1995;333:1750–6.

582.Fibronolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients [published erratum appears in Lancet 1994;343:742]. Lancet. 1994;343:311–22.

583.Goldhaber SZ. Pulmonary embolism thrombolysis: broadening the paradigm for its administration. Circulation. 1997;96:716–8.

584.Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997;30:1165–71.

585.Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review [published erratum appears in JAMA 1998;279:1876]. JAMA. 1997;278:2093–8.

586.Berger PB, Bellot V, Bell MR, et al. An immediate invasive strategy for the treatment of acute myocardial infarction early after noncardiac surgery. Am J Cardiol. 2001;87:1100–2.

587.Cannon CP, Gibson M, Lambrew CT, et al. Relationship of time to treatment and door-to-balloon time to mortality in 27,080 patients with acute myocardial infarction treated with primary angioplasty (abstr). Circulation 1999;100 Suppl I:360.

588.Deleted in proof.

589.McFalls EO, Ward HB, Santilli S, et al. The influence of perioperative myocardial infarction on long-term prognosis following elective vascular surgery. Chest. 1998;113:681–6.

590.Gunnar RM, Passamani ER, Bourdillon PD, et al. Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 1990;16:249–92.

591.Schueppert MT, Kresowik TF, Corry DC, et al. Selection of patients for cardiac evaluation before peripheral vascular operations. J Vasc Surg. 1996;23:802–8.

592.Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions,

201

Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol. 2006;47:1239– 312.

593.Muhlestein JB, Horne BD, Bair TL, et al. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol. 2001;87:257–61.

594.Emlein G, Villegas B, Dahlberg S, et al. Left ventricular cavity size determined by preoperative dipyridamole thallium scintigraphy as a predictor of late cardiac events in vascular surgery patients. Am Heart J. 1996;131:907–14.

595.Klonaris CN, Bastounis EA, Xiromeritis NC, et al. The predictive value of dipyridamole-thallium scintigraphy for cardiac risk assessment before major vascular surgery. Int Angiol. 1998;17:171– 8.

202

СПЕЦИАЛЬНОЕ ДОПОЛНЕНИЕ 2009 ПО ПРИМЕНЕНИЮ БЕТА-

АДРЕНОБЛОКАТОРОВ В ПЕРИОПЕРАЦИОННОМ ПЕРИОДЕ К РЕКОМЕНДАЦИЯМ ПО ПЕРИОПЕРАЦИОННОЙ СЕРДЕЧНО-

СОСУДИСТОЙ ОЦЕНКЕ И ВЕДЕНИЮ ПАЦИЕНТОВ В НЕКАРДИАЛЬНОЙ ХИРУРГИИ

РЕКОМЕНДАЦИИ АМЕРИКАНСКОЙ КОЛЛЕГИИ КАРДИОЛОГОВ И

АМЕРИКАНСКОЙ АССОЦИАЦИИ СЕРДЦА

Редакция русского текста:

Ю.Н. Беленков – член-корр. РАН, действительный член РАМН, д.м.н., профессор Т.А. Батыралиев – заслуженный деятель науки КР, д.м.н., профессор,

FACC, FSCAI, FESC, MEAPCI

Перевод с английского: Д.В. Фетцер – к.м.н., MESC

А.Ж. Арыстанова – д.м.н., FACC

Консультанты:

Б.А. Сидоренко – д.м.н., профессор

Д.В. Преображенский – д.м.н., профессор, FACC, FESC

203

Секция интервенционной кардиологии http://www.scardio.ru/about_vnok/vnok_sections0016C/

Задачи секции

Объединение усилий специалистов – кардиологов, терапевтов, врачей рентгенэндоваскулярных диагностики и лечения, ангиологов, сердечно-сосудистых хирургов в определении места и роли интервенционных методов диагностики и лечения, выработке показаний и противопоказаний к инвазивной диагностике и интервенционному лечению сердечно-сосудистой патологии, а также проведение научно-информационных и практических мероприятий для врачей по вопросам терапии и реваскуляризации.

Председатели секции:

Самко Анатолий Николаевич, Мазаев Владимир Павлович

Заместитель председателя секции:

Першуков Игорь Викторович

Секретарь секции:

Фетцер Денис Витальевич

Контакты для сотрудничества

E-mail: russian_pci@mail.ru

E-mail: russian.pci@gmail.com

204